Potential Class Action Can Proceed In Celexa, Lexapro MDL
By Dani Kass ( June 9, 2016, 5:57 PM EDT) -- A Massachusetts federal judge on Thursday refused to dismiss a potential class action accusing Forest Laboratories Inc. in multidistrict litigation of misleading consumers about the efficacy of its drugs Celexa and Lexapro in treating pediatric depression, finding a mother properly alleged plausible Racketeer Influenced and Corrupt Organizations Act claims....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.